Form D · Biotechnology
FLUIDIGM CORP
South San Francisco, CA · CIK 0001162194
Offering snapshot reported Feb 28, 2014 · SEC filing
- Reported sold
- $76.8M Offering amount: $76.8M
- Investors reported
- 24 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 13, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 28, 2014 | Initial | $76,804,578 | No comparison | 24 | SEC filing |
| Jan 20, 2011 | Initial | $5,000,000 | No comparison | 49 | SEC filing |
| Nov 17, 2009 | Initial | $18,532,822 | No comparison | 101 | SEC filing |
| Aug 31, 2009 | Initial | $10,667,881 | No comparison | 100 | SEC filing |
| Nov 6, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 23, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 11, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 5, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 16, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 27, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 6, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-212727
Source: Form D, filed Feb 28, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gerhard F. Burbach | Director |
| Lawrence Chin | Director |
| Samuel D. Colella | Director |
| Michael Hunkapiller | Director |
| Vikram Jog | Executive |
| Patrick S. Jones | Director |
| Robert C. Jones | Executive |
| Evan Jones | Director |
| Jeremy Loh | Director |
| Kenneth Nussbacher | Director |
| William M. Smith | Executive |
| Fred Walder | Executive |
| Fredric Walder | Executive |
| Raymond Whitaker | Director |
| Gajus V. Worthington | Director, Executive |
| John A. Young | Director |
| Mai Chan Yow | Executive |
| Grace Yow | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7000 Shoreline Court Suite 100
South San Francisco, CA, 94080
South San Francisco, CA, 94080